nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefuroxime—Chills—Paclitaxel—ovarian cancer	0.00156	0.00156	CcSEcCtD
Cefuroxime—Hepatobiliary disease—Docetaxel—ovarian cancer	0.00156	0.00156	CcSEcCtD
Cefuroxime—Hypersensitivity—Melphalan—ovarian cancer	0.00155	0.00155	CcSEcCtD
Cefuroxime—Thrombophlebitis—Doxorubicin—ovarian cancer	0.00154	0.00154	CcSEcCtD
Cefuroxime—Vomiting—Chlorambucil—ovarian cancer	0.00154	0.00154	CcSEcCtD
Cefuroxime—Agranulocytosis—Docetaxel—ovarian cancer	0.00154	0.00154	CcSEcCtD
Cefuroxime—Blood alkaline phosphatase increased—Doxorubicin—ovarian cancer	0.00153	0.00153	CcSEcCtD
Cefuroxime—Hepatic function abnormal—Doxorubicin—ovarian cancer	0.00152	0.00152	CcSEcCtD
Cefuroxime—Pruritus—Topotecan—ovarian cancer	0.00152	0.00152	CcSEcCtD
Cefuroxime—Erythema—Paclitaxel—ovarian cancer	0.00152	0.00152	CcSEcCtD
Cefuroxime—Renal impairment—Epirubicin—ovarian cancer	0.00151	0.00151	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.00151	0.00151	CcSEcCtD
Cefuroxime—Flatulence—Paclitaxel—ovarian cancer	0.00149	0.00149	CcSEcCtD
Cefuroxime—Pruritus—Melphalan—ovarian cancer	0.00149	0.00149	CcSEcCtD
Cefuroxime—Haemoglobin—Docetaxel—ovarian cancer	0.00148	0.00148	CcSEcCtD
Cefuroxime—Haemorrhage—Docetaxel—ovarian cancer	0.00148	0.00148	CcSEcCtD
Cefuroxime—Hepatitis—Docetaxel—ovarian cancer	0.00148	0.00148	CcSEcCtD
Cefuroxime—Diarrhoea—Topotecan—ovarian cancer	0.00147	0.00147	CcSEcCtD
Cefuroxime—Urticaria—Vinorelbine—ovarian cancer	0.00146	0.00146	CcSEcCtD
Cefuroxime—Urinary tract disorder—Docetaxel—ovarian cancer	0.00146	0.00146	CcSEcCtD
Cefuroxime—Muscle spasms—Paclitaxel—ovarian cancer	0.00146	0.00146	CcSEcCtD
Cefuroxime—Abdominal pain—Vinorelbine—ovarian cancer	0.00145	0.00145	CcSEcCtD
Cefuroxime—Body temperature increased—Vinorelbine—ovarian cancer	0.00145	0.00145	CcSEcCtD
Cefuroxime—Urethral disorder—Docetaxel—ovarian cancer	0.00145	0.00145	CcSEcCtD
Cefuroxime—Diarrhoea—Melphalan—ovarian cancer	0.00144	0.00144	CcSEcCtD
Cefuroxime—Nausea—Chlorambucil—ovarian cancer	0.00144	0.00144	CcSEcCtD
Cefuroxime—Dizziness—Topotecan—ovarian cancer	0.00142	0.00142	CcSEcCtD
Cefuroxime—Renal impairment—Doxorubicin—ovarian cancer	0.0014	0.0014	CcSEcCtD
Cefuroxime—Erythema multiforme—Docetaxel—ovarian cancer	0.0014	0.0014	CcSEcCtD
Cefuroxime—Agitation—Paclitaxel—ovarian cancer	0.00139	0.00139	CcSEcCtD
Cefuroxime—Angioedema—Paclitaxel—ovarian cancer	0.00139	0.00139	CcSEcCtD
Cefuroxime—Vomiting—Topotecan—ovarian cancer	0.00137	0.00137	CcSEcCtD
Cefuroxime—Leukopenia—Paclitaxel—ovarian cancer	0.00136	0.00136	CcSEcCtD
Cefuroxime—Rash—Topotecan—ovarian cancer	0.00136	0.00136	CcSEcCtD
Cefuroxime—Hypersensitivity—Vinorelbine—ovarian cancer	0.00136	0.00136	CcSEcCtD
Cefuroxime—Dermatitis—Topotecan—ovarian cancer	0.00136	0.00136	CcSEcCtD
Cefuroxime—Blood creatinine increased—Epirubicin—ovarian cancer	0.00135	0.00135	CcSEcCtD
Cefuroxime—Headache—Topotecan—ovarian cancer	0.00135	0.00135	CcSEcCtD
Cefuroxime—Palpitations—Paclitaxel—ovarian cancer	0.00134	0.00134	CcSEcCtD
Cefuroxime—Angiopathy—Docetaxel—ovarian cancer	0.00134	0.00134	CcSEcCtD
Cefuroxime—Vomiting—Melphalan—ovarian cancer	0.00134	0.00134	CcSEcCtD
Cefuroxime—Immune system disorder—Docetaxel—ovarian cancer	0.00133	0.00133	CcSEcCtD
Cefuroxime—Rash—Melphalan—ovarian cancer	0.00133	0.00133	CcSEcCtD
Cefuroxime—Dermatitis—Melphalan—ovarian cancer	0.00133	0.00133	CcSEcCtD
Cefuroxime—Chills—Docetaxel—ovarian cancer	0.00133	0.00133	CcSEcCtD
Cefuroxime—Cough—Paclitaxel—ovarian cancer	0.00132	0.00132	CcSEcCtD
Cefuroxime—Convulsion—Paclitaxel—ovarian cancer	0.00131	0.00131	CcSEcCtD
Cefuroxime—Pruritus—Vinorelbine—ovarian cancer	0.0013	0.0013	CcSEcCtD
Cefuroxime—Toxic epidermal necrolysis—Epirubicin—ovarian cancer	0.0013	0.0013	CcSEcCtD
Cefuroxime—Chest pain—Paclitaxel—ovarian cancer	0.00129	0.00129	CcSEcCtD
Cefuroxime—Arthralgia—Paclitaxel—ovarian cancer	0.00129	0.00129	CcSEcCtD
Cefuroxime—Erythema—Docetaxel—ovarian cancer	0.00129	0.00129	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.00128	0.00128	CcSEcCtD
Cefuroxime—Nausea—Topotecan—ovarian cancer	0.00128	0.00128	CcSEcCtD
Cefuroxime—Diarrhoea—Vinorelbine—ovarian cancer	0.00126	0.00126	CcSEcCtD
Cefuroxime—Nausea—Melphalan—ovarian cancer	0.00125	0.00125	CcSEcCtD
Cefuroxime—Blood creatinine increased—Doxorubicin—ovarian cancer	0.00125	0.00125	CcSEcCtD
Cefuroxime—Anaphylactic shock—Paclitaxel—ovarian cancer	0.00124	0.00124	CcSEcCtD
Cefuroxime—Muscle spasms—Docetaxel—ovarian cancer	0.00124	0.00124	CcSEcCtD
Cefuroxime—Eosinophilia—Epirubicin—ovarian cancer	0.00123	0.00123	CcSEcCtD
Cefuroxime—Dizziness—Vinorelbine—ovarian cancer	0.00122	0.00122	CcSEcCtD
Cefuroxime—Thrombocytopenia—Paclitaxel—ovarian cancer	0.00121	0.00121	CcSEcCtD
Cefuroxime—Tachycardia—Paclitaxel—ovarian cancer	0.00121	0.00121	CcSEcCtD
Cefuroxime—Skin disorder—Paclitaxel—ovarian cancer	0.0012	0.0012	CcSEcCtD
Cefuroxime—Toxic epidermal necrolysis—Doxorubicin—ovarian cancer	0.0012	0.0012	CcSEcCtD
Cefuroxime—Bronchitis—Epirubicin—ovarian cancer	0.0012	0.0012	CcSEcCtD
Cefuroxime—Hyperhidrosis—Paclitaxel—ovarian cancer	0.0012	0.0012	CcSEcCtD
Cefuroxime—Pancytopenia—Epirubicin—ovarian cancer	0.00118	0.00118	CcSEcCtD
Cefuroxime—Anorexia—Paclitaxel—ovarian cancer	0.00118	0.00118	CcSEcCtD
Cefuroxime—Vomiting—Vinorelbine—ovarian cancer	0.00117	0.00117	CcSEcCtD
Cefuroxime—Dysuria—Epirubicin—ovarian cancer	0.00116	0.00116	CcSEcCtD
Cefuroxime—Neutropenia—Epirubicin—ovarian cancer	0.00116	0.00116	CcSEcCtD
Cefuroxime—Rash—Vinorelbine—ovarian cancer	0.00116	0.00116	CcSEcCtD
Cefuroxime—Dermatitis—Vinorelbine—ovarian cancer	0.00116	0.00116	CcSEcCtD
Cefuroxime—Upper respiratory tract infection—Epirubicin—ovarian cancer	0.00116	0.00116	CcSEcCtD
Cefuroxime—Headache—Vinorelbine—ovarian cancer	0.00115	0.00115	CcSEcCtD
Cefuroxime—Leukopenia—Docetaxel—ovarian cancer	0.00115	0.00115	CcSEcCtD
Cefuroxime—Eosinophilia—Doxorubicin—ovarian cancer	0.00114	0.00114	CcSEcCtD
Cefuroxime—Palpitations—Docetaxel—ovarian cancer	0.00114	0.00114	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.00113	0.00113	CcSEcCtD
Cefuroxime—Cough—Docetaxel—ovarian cancer	0.00112	0.00112	CcSEcCtD
Cefuroxime—Convulsion—Docetaxel—ovarian cancer	0.00111	0.00111	CcSEcCtD
Cefuroxime—Infestation NOS—Epirubicin—ovarian cancer	0.00111	0.00111	CcSEcCtD
Cefuroxime—Infestation—Epirubicin—ovarian cancer	0.00111	0.00111	CcSEcCtD
Cefuroxime—Drowsiness—Epirubicin—ovarian cancer	0.00111	0.00111	CcSEcCtD
Cefuroxime—Bronchitis—Doxorubicin—ovarian cancer	0.00111	0.00111	CcSEcCtD
Cefuroxime—Dyspnoea—Paclitaxel—ovarian cancer	0.0011	0.0011	CcSEcCtD
Cefuroxime—Somnolence—Paclitaxel—ovarian cancer	0.0011	0.0011	CcSEcCtD
Cefuroxime—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.0011	0.0011	CcSEcCtD
Cefuroxime—Arthralgia—Docetaxel—ovarian cancer	0.00109	0.00109	CcSEcCtD
Cefuroxime—Chest pain—Docetaxel—ovarian cancer	0.00109	0.00109	CcSEcCtD
Cefuroxime—Pancytopenia—Doxorubicin—ovarian cancer	0.00109	0.00109	CcSEcCtD
Cefuroxime—Nausea—Vinorelbine—ovarian cancer	0.00109	0.00109	CcSEcCtD
Cefuroxime—Renal failure—Epirubicin—ovarian cancer	0.00109	0.00109	CcSEcCtD
Cefuroxime—Dyspepsia—Paclitaxel—ovarian cancer	0.00109	0.00109	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.00109	0.00109	CcSEcCtD
Cefuroxime—Stomatitis—Epirubicin—ovarian cancer	0.00108	0.00108	CcSEcCtD
Cefuroxime—Jaundice—Epirubicin—ovarian cancer	0.00108	0.00108	CcSEcCtD
Cefuroxime—Urinary tract infection—Epirubicin—ovarian cancer	0.00108	0.00108	CcSEcCtD
Cefuroxime—Dysuria—Doxorubicin—ovarian cancer	0.00108	0.00108	CcSEcCtD
Cefuroxime—Neutropenia—Doxorubicin—ovarian cancer	0.00108	0.00108	CcSEcCtD
Cefuroxime—Decreased appetite—Paclitaxel—ovarian cancer	0.00108	0.00108	CcSEcCtD
Cefuroxime—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.00107	0.00107	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.00107	0.00107	CcSEcCtD
Cefuroxime—Sweating—Epirubicin—ovarian cancer	0.00106	0.00106	CcSEcCtD
Cefuroxime—Pain—Paclitaxel—ovarian cancer	0.00106	0.00106	CcSEcCtD
Cefuroxime—Hepatobiliary disease—Epirubicin—ovarian cancer	0.00105	0.00105	CcSEcCtD
Cefuroxime—Anaphylactic shock—Docetaxel—ovarian cancer	0.00105	0.00105	CcSEcCtD
Cefuroxime—Sinusitis—Epirubicin—ovarian cancer	0.00104	0.00104	CcSEcCtD
Cefuroxime—Agranulocytosis—Epirubicin—ovarian cancer	0.00104	0.00104	CcSEcCtD
Cefuroxime—Thrombocytopenia—Docetaxel—ovarian cancer	0.00103	0.00103	CcSEcCtD
Cefuroxime—Infestation NOS—Doxorubicin—ovarian cancer	0.00103	0.00103	CcSEcCtD
Cefuroxime—Infestation—Doxorubicin—ovarian cancer	0.00103	0.00103	CcSEcCtD
Cefuroxime—Drowsiness—Doxorubicin—ovarian cancer	0.00103	0.00103	CcSEcCtD
Cefuroxime—Tachycardia—Docetaxel—ovarian cancer	0.00102	0.00102	CcSEcCtD
Cefuroxime—Skin disorder—Docetaxel—ovarian cancer	0.00102	0.00102	CcSEcCtD
Cefuroxime—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.00102	0.00102	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.00101	0.00101	CcSEcCtD
Cefuroxime—Renal failure—Doxorubicin—ovarian cancer	0.00101	0.00101	CcSEcCtD
Cefuroxime—Haemoglobin—Epirubicin—ovarian cancer	0.001	0.001	CcSEcCtD
Cefuroxime—Jaundice—Doxorubicin—ovarian cancer	0.001	0.001	CcSEcCtD
Cefuroxime—Stomatitis—Doxorubicin—ovarian cancer	0.001	0.001	CcSEcCtD
Cefuroxime—Anorexia—Docetaxel—ovarian cancer	0.001	0.001	CcSEcCtD
Cefuroxime—Urinary tract infection—Doxorubicin—ovarian cancer	0.000998	0.000998	CcSEcCtD
Cefuroxime—Haemorrhage—Epirubicin—ovarian cancer	0.000996	0.000996	CcSEcCtD
Cefuroxime—Hepatitis—Epirubicin—ovarian cancer	0.000996	0.000996	CcSEcCtD
Cefuroxime—Sweating—Doxorubicin—ovarian cancer	0.000984	0.000984	CcSEcCtD
Cefuroxime—Urinary tract disorder—Epirubicin—ovarian cancer	0.000984	0.000984	CcSEcCtD
Cefuroxime—Urticaria—Paclitaxel—ovarian cancer	0.000983	0.000983	CcSEcCtD
Cefuroxime—Abdominal pain—Paclitaxel—ovarian cancer	0.000979	0.000979	CcSEcCtD
Cefuroxime—Body temperature increased—Paclitaxel—ovarian cancer	0.000979	0.000979	CcSEcCtD
Cefuroxime—Urethral disorder—Epirubicin—ovarian cancer	0.000977	0.000977	CcSEcCtD
Cefuroxime—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.000971	0.000971	CcSEcCtD
Cefuroxime—Sinusitis—Doxorubicin—ovarian cancer	0.000963	0.000963	CcSEcCtD
Cefuroxime—Agranulocytosis—Doxorubicin—ovarian cancer	0.000958	0.000958	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000956	0.000956	CcSEcCtD
Cefuroxime—Erythema multiforme—Epirubicin—ovarian cancer	0.000942	0.000942	CcSEcCtD
Cefuroxime—Dyspnoea—Docetaxel—ovarian cancer	0.000936	0.000936	CcSEcCtD
Cefuroxime—Somnolence—Docetaxel—ovarian cancer	0.000933	0.000933	CcSEcCtD
Cefuroxime—Haemoglobin—Doxorubicin—ovarian cancer	0.000926	0.000926	CcSEcCtD
Cefuroxime—Dyspepsia—Docetaxel—ovarian cancer	0.000924	0.000924	CcSEcCtD
Cefuroxime—Hepatitis—Doxorubicin—ovarian cancer	0.000922	0.000922	CcSEcCtD
Cefuroxime—Haemorrhage—Doxorubicin—ovarian cancer	0.000922	0.000922	CcSEcCtD
Cefuroxime—Decreased appetite—Docetaxel—ovarian cancer	0.000912	0.000912	CcSEcCtD
Cefuroxime—Hypersensitivity—Paclitaxel—ovarian cancer	0.000912	0.000912	CcSEcCtD
Cefuroxime—Urinary tract disorder—Doxorubicin—ovarian cancer	0.00091	0.00091	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000906	0.000906	CcSEcCtD
Cefuroxime—Angiopathy—Epirubicin—ovarian cancer	0.000904	0.000904	CcSEcCtD
Cefuroxime—Urethral disorder—Doxorubicin—ovarian cancer	0.000904	0.000904	CcSEcCtD
Cefuroxime—Immune system disorder—Epirubicin—ovarian cancer	0.0009	0.0009	CcSEcCtD
Cefuroxime—Pain—Docetaxel—ovarian cancer	0.000897	0.000897	CcSEcCtD
Cefuroxime—Chills—Epirubicin—ovarian cancer	0.000894	0.000894	CcSEcCtD
Cefuroxime—Pruritus—Paclitaxel—ovarian cancer	0.000876	0.000876	CcSEcCtD
Cefuroxime—Erythema multiforme—Doxorubicin—ovarian cancer	0.000872	0.000872	CcSEcCtD
Cefuroxime—Erythema—Epirubicin—ovarian cancer	0.000867	0.000867	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000858	0.000858	CcSEcCtD
Cefuroxime—Flatulence—Epirubicin—ovarian cancer	0.000855	0.000855	CcSEcCtD
Cefuroxime—Diarrhoea—Paclitaxel—ovarian cancer	0.000847	0.000847	CcSEcCtD
Cefuroxime—Angiopathy—Doxorubicin—ovarian cancer	0.000836	0.000836	CcSEcCtD
Cefuroxime—Muscle spasms—Epirubicin—ovarian cancer	0.000834	0.000834	CcSEcCtD
Cefuroxime—Immune system disorder—Doxorubicin—ovarian cancer	0.000833	0.000833	CcSEcCtD
Cefuroxime—Abdominal pain—Docetaxel—ovarian cancer	0.00083	0.00083	CcSEcCtD
Cefuroxime—Body temperature increased—Docetaxel—ovarian cancer	0.00083	0.00083	CcSEcCtD
Cefuroxime—Chills—Doxorubicin—ovarian cancer	0.000827	0.000827	CcSEcCtD
Cefuroxime—Dizziness—Paclitaxel—ovarian cancer	0.000819	0.000819	CcSEcCtD
Cefuroxime—Erythema—Doxorubicin—ovarian cancer	0.000802	0.000802	CcSEcCtD
Cefuroxime—Agitation—Epirubicin—ovarian cancer	0.000797	0.000797	CcSEcCtD
Cefuroxime—Flatulence—Doxorubicin—ovarian cancer	0.000791	0.000791	CcSEcCtD
Cefuroxime—Vomiting—Paclitaxel—ovarian cancer	0.000787	0.000787	CcSEcCtD
Cefuroxime—Rash—Paclitaxel—ovarian cancer	0.000781	0.000781	CcSEcCtD
Cefuroxime—Dermatitis—Paclitaxel—ovarian cancer	0.00078	0.00078	CcSEcCtD
Cefuroxime—Leukopenia—Epirubicin—ovarian cancer	0.000776	0.000776	CcSEcCtD
Cefuroxime—Headache—Paclitaxel—ovarian cancer	0.000776	0.000776	CcSEcCtD
Cefuroxime—Hypersensitivity—Docetaxel—ovarian cancer	0.000773	0.000773	CcSEcCtD
Cefuroxime—Muscle spasms—Doxorubicin—ovarian cancer	0.000771	0.000771	CcSEcCtD
Cefuroxime—Palpitations—Epirubicin—ovarian cancer	0.000766	0.000766	CcSEcCtD
Cefuroxime—Cough—Epirubicin—ovarian cancer	0.000757	0.000757	CcSEcCtD
Cefuroxime—Convulsion—Epirubicin—ovarian cancer	0.000751	0.000751	CcSEcCtD
Cefuroxime—Pruritus—Docetaxel—ovarian cancer	0.000742	0.000742	CcSEcCtD
Cefuroxime—Arthralgia—Epirubicin—ovarian cancer	0.000738	0.000738	CcSEcCtD
Cefuroxime—Chest pain—Epirubicin—ovarian cancer	0.000738	0.000738	CcSEcCtD
Cefuroxime—Agitation—Doxorubicin—ovarian cancer	0.000737	0.000737	CcSEcCtD
Cefuroxime—Nausea—Paclitaxel—ovarian cancer	0.000735	0.000735	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000733	0.000733	CcSEcCtD
Cefuroxime—Leukopenia—Doxorubicin—ovarian cancer	0.000718	0.000718	CcSEcCtD
Cefuroxime—Diarrhoea—Docetaxel—ovarian cancer	0.000718	0.000718	CcSEcCtD
Cefuroxime—Palpitations—Doxorubicin—ovarian cancer	0.000709	0.000709	CcSEcCtD
Cefuroxime—Anaphylactic shock—Epirubicin—ovarian cancer	0.000708	0.000708	CcSEcCtD
Cefuroxime—Cough—Doxorubicin—ovarian cancer	0.0007	0.0007	CcSEcCtD
Cefuroxime—Convulsion—Doxorubicin—ovarian cancer	0.000695	0.000695	CcSEcCtD
Cefuroxime—Dizziness—Docetaxel—ovarian cancer	0.000694	0.000694	CcSEcCtD
Cefuroxime—Thrombocytopenia—Epirubicin—ovarian cancer	0.000693	0.000693	CcSEcCtD
Cefuroxime—Tachycardia—Epirubicin—ovarian cancer	0.000691	0.000691	CcSEcCtD
Cefuroxime—Skin disorder—Epirubicin—ovarian cancer	0.000687	0.000687	CcSEcCtD
Cefuroxime—Hyperhidrosis—Epirubicin—ovarian cancer	0.000684	0.000684	CcSEcCtD
Cefuroxime—Chest pain—Doxorubicin—ovarian cancer	0.000683	0.000683	CcSEcCtD
Cefuroxime—Arthralgia—Doxorubicin—ovarian cancer	0.000683	0.000683	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000678	0.000678	CcSEcCtD
Cefuroxime—Anorexia—Epirubicin—ovarian cancer	0.000675	0.000675	CcSEcCtD
Cefuroxime—Vomiting—Docetaxel—ovarian cancer	0.000667	0.000667	CcSEcCtD
Cefuroxime—Rash—Docetaxel—ovarian cancer	0.000662	0.000662	CcSEcCtD
Cefuroxime—Dermatitis—Docetaxel—ovarian cancer	0.000661	0.000661	CcSEcCtD
Cefuroxime—Headache—Docetaxel—ovarian cancer	0.000657	0.000657	CcSEcCtD
Cefuroxime—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000655	0.000655	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000645	0.000645	CcSEcCtD
Cefuroxime—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000641	0.000641	CcSEcCtD
Cefuroxime—Tachycardia—Doxorubicin—ovarian cancer	0.000639	0.000639	CcSEcCtD
Cefuroxime—Skin disorder—Doxorubicin—ovarian cancer	0.000636	0.000636	CcSEcCtD
Cefuroxime—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000633	0.000633	CcSEcCtD
Cefuroxime—Dyspnoea—Epirubicin—ovarian cancer	0.000631	0.000631	CcSEcCtD
Cefuroxime—Somnolence—Epirubicin—ovarian cancer	0.000629	0.000629	CcSEcCtD
Cefuroxime—Anorexia—Doxorubicin—ovarian cancer	0.000624	0.000624	CcSEcCtD
Cefuroxime—Nausea—Docetaxel—ovarian cancer	0.000623	0.000623	CcSEcCtD
Cefuroxime—Dyspepsia—Epirubicin—ovarian cancer	0.000623	0.000623	CcSEcCtD
Cefuroxime—Decreased appetite—Epirubicin—ovarian cancer	0.000615	0.000615	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000611	0.000611	CcSEcCtD
Cefuroxime—Pain—Epirubicin—ovarian cancer	0.000605	0.000605	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000597	0.000597	CcSEcCtD
Cefuroxime—Dyspnoea—Doxorubicin—ovarian cancer	0.000584	0.000584	CcSEcCtD
Cefuroxime—Somnolence—Doxorubicin—ovarian cancer	0.000582	0.000582	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000579	0.000579	CcSEcCtD
Cefuroxime—Dyspepsia—Doxorubicin—ovarian cancer	0.000576	0.000576	CcSEcCtD
Cefuroxime—Decreased appetite—Doxorubicin—ovarian cancer	0.000569	0.000569	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000565	0.000565	CcSEcCtD
Cefuroxime—Urticaria—Epirubicin—ovarian cancer	0.000562	0.000562	CcSEcCtD
Cefuroxime—Pain—Doxorubicin—ovarian cancer	0.00056	0.00056	CcSEcCtD
Cefuroxime—Abdominal pain—Epirubicin—ovarian cancer	0.000559	0.000559	CcSEcCtD
Cefuroxime—Body temperature increased—Epirubicin—ovarian cancer	0.000559	0.000559	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000536	0.000536	CcSEcCtD
Cefuroxime—Hypersensitivity—Epirubicin—ovarian cancer	0.000521	0.000521	CcSEcCtD
Cefuroxime—Urticaria—Doxorubicin—ovarian cancer	0.00052	0.00052	CcSEcCtD
Cefuroxime—Abdominal pain—Doxorubicin—ovarian cancer	0.000518	0.000518	CcSEcCtD
Cefuroxime—Body temperature increased—Doxorubicin—ovarian cancer	0.000518	0.000518	CcSEcCtD
Cefuroxime—Pruritus—Epirubicin—ovarian cancer	0.000501	0.000501	CcSEcCtD
Cefuroxime—Diarrhoea—Epirubicin—ovarian cancer	0.000484	0.000484	CcSEcCtD
Cefuroxime—Hypersensitivity—Doxorubicin—ovarian cancer	0.000482	0.000482	CcSEcCtD
Cefuroxime—Dizziness—Epirubicin—ovarian cancer	0.000468	0.000468	CcSEcCtD
Cefuroxime—Pruritus—Doxorubicin—ovarian cancer	0.000463	0.000463	CcSEcCtD
Cefuroxime—Vomiting—Epirubicin—ovarian cancer	0.00045	0.00045	CcSEcCtD
Cefuroxime—Diarrhoea—Doxorubicin—ovarian cancer	0.000448	0.000448	CcSEcCtD
Cefuroxime—Rash—Epirubicin—ovarian cancer	0.000446	0.000446	CcSEcCtD
Cefuroxime—Dermatitis—Epirubicin—ovarian cancer	0.000446	0.000446	CcSEcCtD
Cefuroxime—Headache—Epirubicin—ovarian cancer	0.000443	0.000443	CcSEcCtD
Cefuroxime—Dizziness—Doxorubicin—ovarian cancer	0.000433	0.000433	CcSEcCtD
Cefuroxime—Nausea—Epirubicin—ovarian cancer	0.00042	0.00042	CcSEcCtD
Cefuroxime—Vomiting—Doxorubicin—ovarian cancer	0.000416	0.000416	CcSEcCtD
Cefuroxime—Rash—Doxorubicin—ovarian cancer	0.000413	0.000413	CcSEcCtD
Cefuroxime—Dermatitis—Doxorubicin—ovarian cancer	0.000413	0.000413	CcSEcCtD
Cefuroxime—Headache—Doxorubicin—ovarian cancer	0.00041	0.00041	CcSEcCtD
Cefuroxime—Nausea—Doxorubicin—ovarian cancer	0.000389	0.000389	CcSEcCtD
